-
FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions.
-
-
-
Dowson and colleagues performed a randomized, controlled trial to assess the efficacy of PFO closure in reducing the incidence of migraine with aura.
-
Vernakalant is a new investigational anti- arrhythmic drug. The compound is relatively selective, blocking the early-activating potassium channel and the frequency-dependent sodium channel.
-
Kim YH. Health benefits of Tai Chi. 2008;11:53-56.
-
Greenfield RH. “When in China…” – Berberine and diabetes. 2008;11:57-58.
Greenfield RH. Ouch! Priorities and acute pancreatitis. 2008;11:58-59.
Greenfield RH. Stress, childhood illness and immunity. 2008;11:59-60.
-
-
Bongaard B. Using acupuncture for headache treatment: Getting the point! 2008;11:49-52.
-
This phase II placebo-controlled trial showed a dramatic benefit from rituximab in preventing clinical relapses, as well as new MRI lesions, in patients with multiple sclerosis (MS).
